Market Cap 48.67M
Revenue (ttm) 83.81M
Net Income (ttm) -240.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -287.22%
Debt to Equity Ratio -2.02
Volume 1,245,100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 9.79M
Stochastic %K N/A
Beta 0.27
Analysts Hold
Price Target $9.33

Company Profile

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company's product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; LYFGENIA (lovotibeglogene autotemcel) for the treatment of sickle cell disease (SCD) and a history of vaso-occlusive events; and SKYSONA (elivaldogene autotemcel) to treat cereb...

Industry: Biotechnology
Sector: Healthcare
Phone: 339 499 9300
Address:
455 Grand Union Boulevard, Somerville, United States
Tumble51
Tumble51 Aug. 6 at 8:10 PM
$CADL $BLUE sold for that , just saying , haha
0 · Reply
Luckypig
Luckypig Aug. 6 at 12:52 AM
$IOVA I hope that i'm wrong, but I don't see us receiving positive news with ER. Mgmt needs to temporarily increase the treatment price from $560K to whatever the price should be until we are breakeven. Once we are breakeven then lower the treatment price. It does not help anyone if we go out of business like $BLUE. We need to be more like $ABEO, they recently received their FDA approval, they charge $3.1M per one-time treatment and will be profitable by 1qt 2026. At the current rate $IOVA will need to dilute again lowering our share price again and eventually either go bankrupt or be sold for pennies on the $. Again, I hope I'm wrong but the foggy path seems to not be on a healthy path "UNLESS" mgmt changes. All the best to everyone that supports Iovance. GLTA!!!
2 · Reply
MF__DOOM
MF__DOOM Aug. 5 at 4:23 AM
$BLUE $CG $CRSP $XBI Back to price before director (insider) bought 50mil+ I will be adding more puts to the table come this week though the insider buy was still incredibly bullish but technicals still say short term pain could come before long term bullish swing
0 · Reply
Jadek6
Jadek6 Aug. 4 at 12:09 PM
$BLUE $CADL not as yet !
0 · Reply
Dkll303
Dkll303 Aug. 3 at 6:31 PM
$BLUE $CADL $SAVA Did Mary Jane say hello to you , Jade ? ..he did to me , lol
0 · Reply
Jadek6
Jadek6 Aug. 3 at 5:19 PM
$CADL Keep convincing yourself @yogi888, like they did at $BLUE , HAAHAH. OH , SAY HI TO @FreedSage2013 $BLUE was going to $100. Sold for 300M , lol $SAVA to $250 ….Phase3 FAILED
1 · Reply
RUMPOTUS
RUMPOTUS Aug. 3 at 3:53 AM
$BLUE bluefin on $SUI
0 · Reply
Jadek6
Jadek6 Aug. 1 at 11:51 PM
$CADL well, like what happened at $BLUE,,Nick Leschly , CEO, LIED, To the street and TAK has followed in his footsteps !!! Blue was sold for 300M , lol ..after having a market cap of 11B TAK will fcuk this up ..his tall tales will haunt this like Remi at $SAVA , and his lies , haunted that til the DOJ walked in ! You should fear …Manning group has lost 1B on bios Baker Bros aren’t that bright You don’t see Frazier life sciences in the 13D/13F filings Ha ha
0 · Reply
Tumble51
Tumble51 Aug. 1 at 5:11 PM
$AGIO Good wholesome senior execs win out ALNY RYTM Misfits lose $CADL $NTLA $AGIO $BLUE $REPL
0 · Reply
fantastex
fantastex Jul. 31 at 6:50 PM
$REPL who s holding up this scam company? This is a next $BLUE This
1 · Reply
Latest News on BLUE
Bluebird bio receives non-binding bid for up to $110.5 million

Mar 28, 2025, 5:43 PM EDT - 4 months ago

Bluebird bio receives non-binding bid for up to $110.5 million


bluebird bio Announces 1-for-20 Reverse Stock Split

Dec 4, 2024, 4:05 PM EST - 8 months ago

bluebird bio Announces 1-for-20 Reverse Stock Split


bluebird bio, Inc. (BLUE) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 10:06 AM EST - 9 months ago

bluebird bio, Inc. (BLUE) Q3 2024 Earnings Call Transcript


Bluebird Bio (BLUE) Stock Dips Amid Market Volatility

Oct 8, 2024, 3:53 PM EDT - 10 months ago

Bluebird Bio (BLUE) Stock Dips Amid Market Volatility


Bluebird Bio (BLUE) Stock Surges 5.04% Amid Market Movements

Oct 2, 2024, 4:11 PM EDT - 11 months ago

Bluebird Bio (BLUE) Stock Surges 5.04% Amid Market Movements


bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing

Sep 27, 2024, 4:30 PM EDT - 11 months ago

bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing


Bluebird bio to cut 25% of workforce as part of restructuring

Sep 24, 2024, 7:08 AM EDT - 11 months ago

Bluebird bio to cut 25% of workforce as part of restructuring


bluebird bio Announces September Investor Events

Aug 28, 2024, 8:00 AM EDT - 1 year ago

bluebird bio Announces September Investor Events


bluebird bio, Inc. (BLUE) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 11:14 AM EDT - 1 year ago

bluebird bio, Inc. (BLUE) Q2 2024 Earnings Call Transcript


Tumble51
Tumble51 Aug. 6 at 8:10 PM
$CADL $BLUE sold for that , just saying , haha
0 · Reply
Luckypig
Luckypig Aug. 6 at 12:52 AM
$IOVA I hope that i'm wrong, but I don't see us receiving positive news with ER. Mgmt needs to temporarily increase the treatment price from $560K to whatever the price should be until we are breakeven. Once we are breakeven then lower the treatment price. It does not help anyone if we go out of business like $BLUE. We need to be more like $ABEO, they recently received their FDA approval, they charge $3.1M per one-time treatment and will be profitable by 1qt 2026. At the current rate $IOVA will need to dilute again lowering our share price again and eventually either go bankrupt or be sold for pennies on the $. Again, I hope I'm wrong but the foggy path seems to not be on a healthy path "UNLESS" mgmt changes. All the best to everyone that supports Iovance. GLTA!!!
2 · Reply
MF__DOOM
MF__DOOM Aug. 5 at 4:23 AM
$BLUE $CG $CRSP $XBI Back to price before director (insider) bought 50mil+ I will be adding more puts to the table come this week though the insider buy was still incredibly bullish but technicals still say short term pain could come before long term bullish swing
0 · Reply
Jadek6
Jadek6 Aug. 4 at 12:09 PM
$BLUE $CADL not as yet !
0 · Reply
Dkll303
Dkll303 Aug. 3 at 6:31 PM
$BLUE $CADL $SAVA Did Mary Jane say hello to you , Jade ? ..he did to me , lol
0 · Reply
Jadek6
Jadek6 Aug. 3 at 5:19 PM
$CADL Keep convincing yourself @yogi888, like they did at $BLUE , HAAHAH. OH , SAY HI TO @FreedSage2013 $BLUE was going to $100. Sold for 300M , lol $SAVA to $250 ….Phase3 FAILED
1 · Reply
RUMPOTUS
RUMPOTUS Aug. 3 at 3:53 AM
$BLUE bluefin on $SUI
0 · Reply
Jadek6
Jadek6 Aug. 1 at 11:51 PM
$CADL well, like what happened at $BLUE,,Nick Leschly , CEO, LIED, To the street and TAK has followed in his footsteps !!! Blue was sold for 300M , lol ..after having a market cap of 11B TAK will fcuk this up ..his tall tales will haunt this like Remi at $SAVA , and his lies , haunted that til the DOJ walked in ! You should fear …Manning group has lost 1B on bios Baker Bros aren’t that bright You don’t see Frazier life sciences in the 13D/13F filings Ha ha
0 · Reply
Tumble51
Tumble51 Aug. 1 at 5:11 PM
$AGIO Good wholesome senior execs win out ALNY RYTM Misfits lose $CADL $NTLA $AGIO $BLUE $REPL
0 · Reply
fantastex
fantastex Jul. 31 at 6:50 PM
$REPL who s holding up this scam company? This is a next $BLUE This
1 · Reply
Jadek6
Jadek6 Jul. 31 at 1:01 PM
$CADL almost like $BLUE ..two,years ago , hahaha Then a r/s and sold for 300M. Oh well Keep the mouth going TAk..they did at Bluebird bio But the street hated Nick Leschly,,who fcuked the street over
0 · Reply
lasmanoz
lasmanoz Jul. 19 at 9:32 PM
$BLUE whats going on here? someone explain?
2 · Reply
QLBatiatus
QLBatiatus Jul. 15 at 3:56 PM
$BLUE The hate I have for the managers of this disaster is epic. What a shame for patients …this was my last foray into bio Pharma - f Pharma stocks and bios - corruption, incompetence, lawsuits….never again!!!!
0 · Reply
MF__DOOM
MF__DOOM Jul. 14 at 5:20 PM
$CRSP easy short, the same people who blocked me when this hit $32-30 range from $50S are the same ones who will miss out on money again and not ride this back down to $45-40 range Also collected a nice call premium riding Crspr from $32 to lower $50 I said it for a year crispr would touch lower $30S and so many posted against me that most now blocked me when we hit $31 range 😂 I’m not a premabear like some think because I came from $BLUE but I said it almost 2 years ago now once blue began collapsing in the buyout process that $CRSP was gonna follow and it did Also many who post against me said neither blue nor crispr was gonna get bought out…blue got Bo and said it 3-4years+ ago now at this point and it was so obvious back then (the fact that it got an incredibly shitty BO was a little harder to predict, sadly) Now with blue in private sector by Carlyle many of you will get caught off by price action based on the board posts here, don’t be fooled by perma bulls…this does have potential if this stock goes the right way but on a technical level it’s over extended now so if you’re long term keep holding and wait a little to avg. down/up because price in the short term is gonna get much cheaper and once those targets ($45-40) are reached and if news comes out accordingly then this could see $80-100 but currently that ain’t gonna be a straight line upward. $CG $XBI
3 · Reply
gargoyl
gargoyl Jul. 9 at 3:12 PM
$BLRX 👀 runner ?? 🏃‍♀️ 🩳 * * * 🔫 Percolating $BMY $VSTM @ peeps at $BLUE
0 · Reply
Rnerdz
Rnerdz Jul. 9 at 12:18 PM
$BLUE who’s buyin??
1 · Reply
gargoyl
gargoyl Jul. 7 at 5:17 PM
$BLUE back to $5 , life is good
0 · Reply
Harvard_MBA
Harvard_MBA Jul. 3 at 4:59 PM
$IOVA, you are likely right. This company simply has no plan on how to make money. The treatment is simply too complex and too expensive and the patient pool too small. If there is a market downdraft this could be below a $1 in a blink. I believe the best strategy is to shelve their pipeline and try and find a private equity firm to take them over. Much like $BLUE. A $70M market cap sounds reasonable.
3 · Reply
Obiwan123
Obiwan123 Jul. 3 at 2:21 PM
$BLUE the company that ruined their shareholders.
0 · Reply
Estimize
Estimize Jul. 2 at 10:00 PM
Wall St is expecting -2.52 EPS for $BLUE Q2 [Reporting 08/12 BMO] http://www.estimize.com/intro/blue?chart=historical&metric_name=eps&utm_c
0 · Reply
GoldenTradesCapital
GoldenTradesCapital Jun. 30 at 8:29 AM
MARKET UPDATE: TOP NASDAQ LOSERS THIS WEEK 📉 • $LCID -12.3% • $CVNA -10.8% • $BBBYQ -10.1% • $NKLA -9.5% • $BLUE -8.9% Follow us to stay on top of the market 🔱
0 · Reply
Letsinvest2024
Letsinvest2024 Jun. 28 at 9:58 PM
$BLUE I wanted to choose the $5 cash option but I missed the due date.🙄 At least I still have some rights in the future. Per ChatGPT: While it's possible for a company to manipulate operations to avoid a CVR payout, doing so can lead to serious legal, financial, and reputational consequences. CVR holders often have contractual and legal protections to challenge such actions. If you’re involved with a CVR — as a holder or within a company — it’s wise to consult with legal counsel to understand your rights and obligations.
0 · Reply